TRDMT1 and breast cancer: BRCA1 depletion in the HR-proficient breast cancer cell line HS578T significantly increased TRDMT1i sensitivity (Fig. 6a), showing that TRDMT1 indeed has a BRCA1-independent function that is critical for the survival of BRCA1-deficient cells.